-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeting Complement to Treat Hematologic Disease

Program: General Sessions
Session: Presidential Symposium
Tuesday, December 12, 2023, 11:00 AM-12:30 PM

Eleni Gavriilaki, MD, PhD

Aristotle University of Thessaloniki, Thessaloniki, Greece

Disclosures: Gavriilaki: Pfizer and Jazz Pharmaceuticals: Research Funding; Alexion, AstraZeneca, Omeros, Sanofi, Sobi: Honoraria.

See more of: Presidential Symposium
See more of: General Sessions
<< Previous Presentation | Next Presentation